Mayfair Laboratories Limited

Active12469779 Private limited company
Incorporated
18 February 2020 (6 years)
Previously known as
Prism Medical Supplies Ltd (until 29 December 2021)
Pyramid Medical Limited (until 17 August 2020)
Eurasia Pharmaceticals Ltd (until 14 August 2020)
Industry
Business and domestic software development (62012)
Information technology consultancy activities (62020)
Regulation of health care, education, cultural and other social services, not incl. social security (84120)
Other human health activities (86900)
Directors
Yasemin Karahan
Muberra Dogru
Owned by
Muberra Dogru
Accounts type
Micro entity
Region
North West
Address
23 Stanton Avenue
Manchester
M20 2PG

Filing status

Accounts due
30 November 2026
Last accounts
28 February 2025
Conf. stmt due
20 November 2027
Last conf. stmt
6 November 2026

Officers

This list may be incomplete. See all officers on Companies House

Officer details are public data from the Companies House register.

Karahan, Yasemin
Director · Appointed 7 April 2025
Serbian,Turkish
Born February 1983 (43)
Dogru, Muberra
Director · Appointed 17 February 2024
Turkish
Born December 1980 (45)
Officer history (3 former)
7 April 2025
Appointed Karahan, Yasemin as Director
17 February 2024
Appointed Dogru, Muberra as Director
17 February 2024
Appointed Karahan, Gokhan as Director
17 February 2024
Resigned Karahan, Gokhan as Director
17 February 2024
Resigned Naseef, Samir, Dr as Director
21 September 2021
Resigned Jariwala, Hemesh as Director
25 July 2020
Appointed Jariwala, Hemesh as Director
18 February 2020
Appointed Naseef, Samir, Dr as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Muberra Dogru
Individual · Notified 17 February 2024
Owns 50–75% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
Turkish
Born December 1980 (45)
Former controllers (2)
13 June 2026
Ceased Savas Dogru — Has significant influence or control
17 February 2024
Ceased Samir Naseef — Owns 75–100% of shares

Financials

Balance sheet as at 28 February 2025 · micro entity accounts

Net Assets
(£5,682)
Debt Ratio
113%
Current Ratio
0.5x

Trend

Net Assets
(£40k) (£20k) £0 £20k 2021 2022 2023 2024 2025 £154 (£24,335) (£18,876) (£19,733) (£5,682)
Balance sheet detail
20252024202320222021
Fixed Assets£19,212£21,444£21,444£3,145
Current Assets£25,380£2,831£5,565£5,897£2,772
Creditors (< 1 year)£49,914£44,613£45,525£33,017£2,618
Net Current Assets(£24,534)(£41,782)(£39,960)(£27,120)£154
Net Assets(£5,682)(£19,733)(£18,876)(£24,335)£154
Shareholder Funds(£5,682)(£19,733)(£18,876)(£24,335)£154

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
6 November 2026Confirmation statement with updates6 November 2026
26 October 2026Confirmation statement with updates26 October 2026
13 August 2026Confirmation statement with no updates30 June 2026
20 June 2026Cessation of a person with significant control
28 November 2025Micro company accounts28 February 2025
Show all recent filings

Other companies in this industry

By trade and location

New Software Companies →New companies in Manchester →New Software Companies in Manchester →

Explore the largest companies

Largest software & technology companies in the UK →Largest companies in Manchester, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?